EUROPEAN ONCOLOGY LAB AS
Operating
Tilby legetjenester innen klinisk medisin, forskning og undervisning
samt aktivt å investere i selskaper innenfor sektorene helse,
forskning og utvikling.
Legetjenester.
Organization
- Chairman of the board
- HJ
- Years since formation
- 7 years
- since Feb 11, 2019
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30,000
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2025
- 93,500
- NOK
- Annual total result 2025
- 41,557
- NOK
- Total equity 2025
- -27,130
- NOK
Last update: Jul 2, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
HJ | Chairman | 8.22 % indirectly |
DS | Board Member | 31.3 % indirectly |
RL 1971 | Board Member | 31.3 % indirectly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
DS | Board Member | 31.3 % indirectly |
RL 1971 | Board Member | 31.3 % indirectly |
HH | - | 8.22 % indirectly |
HJ | Chairman | 8.22 % indirectly |
EH | - | 8.22 % indirectly |
OH | - | 8.22 % indirectly |
HA 1971 | - | 1.23 % indirectly |
Last update: May 4, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 30,000 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2025: NOK 2,523,951Operating profit 2025: NOK 179,501Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 93,500 | 33,159 | 0 | 0 | 0 |
Annual Total Result | 41,557 | -59,759 | 0 | 0 | -36,421 |
Total assets | 26,905 | 55,718 | 109 | 12,918 | 12,918 |
Total liabilities | 54,035 | 124,404 | 9,035 | 21,844 | 21,844 |
Total equity | -27,130 | -68,687 | -8,926 | -8,926 | -8,926 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 93,500 | 33,159 | 0 | 0 | 0 |
Total operating costs | 51,796 | 91,733 | 0 | 0 | 0 |
Operating result | 41,704 | -58,574 | 0 | 0 | 0 |
Financial income/costs | -147 | -1,185 | 0 | 0 | -36,421 |
Profit before tax | 41,557 | -59,759 | 0 | 0 | -36,421 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | 41,557 | -59,759 | 0 | 0 | -36,421 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 12,809 | 0 |
Total current assets | 26,905 | 55,718 | 109 | 109 | 12,918 |
Total assets | 26,905 | 55,718 | 109 | 12,918 | 12,918 |
Short term debt | 9,035 | 24,404 | 9,035 | 21,844 | 21,844 |
Long term debt | 45,000 | 100,000 | 0 | 0 | 0 |
Total liabilities | 54,035 | 124,404 | 9,035 | 21,844 | 21,844 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 |
Retained earnings | -57,130 | -98,687 | -38,926 | -38,926 | -38,926 |
Total equity | -27,130 | -68,687 | -8,926 | -8,926 | -8,926 |
Total equity and liabilities | 26,905 | 55,717 | 109 | 12,918 | 12,918 |
Classification
21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises